Clinical Trial Details

Trial ID: L0965
Source ID: JPRN-UMIN000002641
Associated Drug: Telmisartan
Title: A open label, randomized, controled trial to assess the usefulness of telmisartan in patients with type 2 diabetes, obesity, and NAFLD
Acronym: --
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: type 2 diabetes mellitus
Interventions: (Telmisartan group)<br>Patients under treatment with telmisartan (40mg/day) are switched from valsartan (80mg/day) to telmisartan at the dose of 40mg/day for 6months.<br>(Valsartan group)<br>Patients under treatment with valsartan (80mg/day) group will co
Outcome Measures: Content of visceral fat and fatty liverHbA1c, fasting glucose, fasting CPR, ABI/PWV, body weight, blood pressure
Sponsor/Collaborators: MATSUYAMA SHIMIN HOSPITAL
Gender: All
Age: 20years-oldNot applicable
Phases: Not applicable
Enrollment: 50
Study Type: Interventional
Study Designs: Parallel Randomized
Start Date: 21/10/2009
Completion Date: --
Results First Posted: --
Last Update Posted: 2 April 2019
Locations: Japan
URL: https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003219